Team
Co-founder & CEO
Ildiko Mehes
20+ year pharmaceutical industry executive, board member, and investor advisor, with deep and broad experience, including in R&D and IP.
Learn more
Scientific Director
Andrey Feklistov
Stanford molecular biologist with 20+ years experience in biochemistry, X-ray crystallography, cryo-EM and computational methods.
Learn more
Cofounder & President
Zach Sherman
Serial entrepreneur and engineer with multiple exits. Founder of Timber Technologies, an infrastructure monitoring company which sold to Datadog in 2021.
Learn more
Operations
Ross Berger
Former VP of Patient Operations at Simple Health and VP of Operations at Mockingbird. Builder and entrepreneur.
Learn moreAdvisors
Advisor
Bram Verstockt
Professor at KU Leuven, staff member of the Department of Gastroenterology and Hepatology at the University Hospitals Leuven. GI clinician/ researcher and a frequent author and speaker on IBD-related research.
Learn more
Advisor
Mark Silverberg
Gastroenterologist, researcher and globally-recognized leader in the field of IBD. PhD in the genetics of IBD and is a Professor in the Department of Medicine at the University of Toronto.
Learn more
Medicinal Chemistry
Stevan Djuric
Former head of the global AbbVie medicinal chemistry. High throughput synthesis and purification, hit-to-lead chemistry, chemical biology and new MS-based analytical technologies.
Learn more
Advisor
Charles Bernstein
Researcher at the University of Manitoba studying the epidemiology and underlying mechanisms of inflammatory bowel disease. Director of the University of Manitoba IBD Epidemiology Database.
Learn more
Medicinal Chemistry
Robert Dow
Former medicinal chemist at Pfizer. Ph.D. in synthetic organic chemistry (California Institute of Technology & Harvard University). His contributions have led to the discovery of 14 agents that have entered clinical trials.
Learn more